BMP-9 and LDL crosstalk regulates ALK-1 endocytosis and LDL transcytosis in endothelial cells
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (52) , 18179-18188
Abstract
No abstract availableKeywords
Funding Information
- HHS | NIH | National Heart, Lung, and Blood Institute (R35HL139945)
- HHS | NIH | National Heart, Lung, and Blood Institute (PO1HL107205)
- American Heart Association (MERIT)
- HHS | NIH | National Heart, Lung, and Blood Institute (R35HL135820)
- Canada Research Chairs (PJT-168947)
This publication has 25 references indexed in Scilit:
- Endothelial Transcytosis of Lipoproteins in AtherosclerosisFrontiers in Cardiovascular Medicine, 2018
- Regulation of the ALK1 ligands, BMP9 and BMP10Biochemical Society Transactions, 2016
- A novel assay uncovers an unexpected role for SR-BI in LDL transcytosisCardiovascular Research, 2015
- Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertensionNature Medicine, 2015
- BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomainCellular and Molecular Life Sciences, 2011
- Genetic Evidence Supporting a Critical Role of Endothelial Caveolin-1 during the Progression of AtherosclerosisCell Metabolism, 2009
- Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence FactorCirculation Research, 2008
- Activin-like kinase receptor 1 (ALK1) in atherosclerotic lesions and vascular mesenchymal cellsCardiovascular Research, 2007
- Genetic Ablation of Caveolin-1 Confers Protection Against AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Distinction between signaling mechanisms in lipid rafts vs. caveolaeProceedings of the National Academy of Sciences, 2001